[The effect of the vasoconstrictor glycylpressin on the bioavailability of mitomycin C]

Arch Pharm (Weinheim). 1991 Jan;324(1):25-7. doi: 10.1002/ardp.19913240108.
[Article in German]

Abstract

During an intra-arterial chemotherapy of patients with liver metastases the plasma concentration-time curves of Mitomycin C (1) after occlusion of the common hepatic artery by the vasoconstricting agent Glycylpressin (2) were investigated. Vasoconstriction by 2 leads to significantly (p less than 0.01) lower blood levels of 1 in contrast to bolus injection of 1 without 2 under identical dosage regimens. This reduction of systemic availability of about 50% leads to a corresponding higher availability for the tumor region.

MeSH terms

  • Aged
  • Biological Availability
  • Drug Interactions
  • Humans
  • Lypressin / analogs & derivatives*
  • Lypressin / pharmacology
  • Male
  • Middle Aged
  • Mitomycin
  • Mitomycins / pharmacokinetics*
  • Terlipressin
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Mitomycins
  • Vasoconstrictor Agents
  • Lypressin
  • Mitomycin
  • Terlipressin